Apply the drug only under the supervision of a doctor.
To draw into the syringe a contrast substance is necessary immediately before the beginning of the examination. The solution of contrast medium is intended for single use only. For the prevention of thrombosis, angiography, it is often necessary to flush the intravenous catheter with saline solution of sodium chloride. Before use, the preparation should be heated to body temperature. The solution is administered in the patient's "lying" position.
For intracavitary administration (in the bladder, renal pelvis), Triombrast® should be diluted with an isotonic solution of sodium chloride or 5% glucose solution until a 30% solution is obtained.
Angiography.
Preparation of the patient for angiography: at night appoint tranquilizers, in the evening and in the morning - cleansing enema; on the day of the study, the patient should not take food.
Triombrast® is administered intraarterially for angiocardiography, aortography, arteriography, selective angiography. Phlebography, as well as splenoportografiya carried out by intravenous injection.
Phlebography: for the lower limbs, 20-40 ml is injected, for the upper ones - 10-20 ml of 60% Triombrast® solution at a rate of 3-5 ml / sec. When examining the vena cava, the drug is administered in an amount of 25-30 ml at a rate of 10-13 ml / s. Pictures are taken already during the administration of the drug. After the examination it is necessary to ensure the removal of the contrast agent from the extremities: the limb is lifted and the vein is washed with 50-70 ml of 0.9% sodium chloride solution.
Peripheral arteriography: 20 ml are used for the lower limbs, and 60% solution for the upper extremities.For better tolerability, it is recommended that the drug be administered in a direction opposite to the blood flow.
Cerebral angiography: on average, 7 ml of a 60% solution is injected into the carotid artery or 4 ml is injected into the vertebral artery. With simultaneous seriography in 2 planes, 1 injection is enough, otherwise for the second projection, you need to repeat the injection. The solution is injected rapidly (10 ml in about 1.5 s).
Aortography: 30-50 ml 76% solution intra-abortally at a rate of 8 ml / sec.
Digital (digital) arteriography: inject 60% solution in an amount, corresponding to the blood flow of the examined artery.
Angiocardiography: Introduce up to 60 ml of 76% solution at a rate of 8 ml / sec.
Splenoportography: Introduce 20-30 ml of a 76% solution of Triombrast® at a rate of 8 ml / s.
Examination of the urinary tract.
Preparation of the patient for research: the day before the study, the diet of the patient should not contain products that cause fermentation and swelling of the intestine. It is recommended to exclude from the diet dairy products, fruits, vegetables, salads, smoked products, rough black or freshly baked bread. The night before and in the morning before the study - cleansing enemas.Immediately before the test, it is necessary to empty the bladder. The study is performed on an empty stomach. Excretory urography: 20-40 ml of a 60% solution warmed to body temperature, slowly injected into the ulnar vein. For unprepared (without cleansing enema) or obese patients, it is better to use 76% solution in the same amount. With a decreased function of the kidneys, I / drip in, diluting in 250-300 ml of 5% glucose, for 5-10 minutes.
Ascending pyelography: 5-10 ml of a 30% solution is slowly injected with a catheter; When there is any pain or pressure in the kidneys, the injection stops. Cystography: average 60-80 ml of a 30% solution (after a preliminary dilution of Triombrast® 60% in a 1: 2 ratio with isotonic sodium chloride solution or 5% glucose solution to 30%) into the external opening of the urethra or 20 ml when the catheter is inserted bladder with air (lacunar cystography).
Cholangiography: 5-20 ml of a 30% solution of Triombrast® (after a preliminary dilution of Triombrast 60% in a 1: 2 ratio with isotonic sodium chloride solution or 5% glucose solution to obtain 30%) is introduced;
Аоттюграфия: 30% solution (after preliminary dilution of Triombrast® 60% in a ratio of 1: 2 with isotonic sodium chloride solution or 5% glucose solution to 30%), warmed to body temperature, slowly enter in the required amount after the usual disinfection of the joint. Triombrast® is administered after removal of the exudate under aseptic conditions. The solution is administered in the patient's "lying" position. To dilute the solution, use only water for injection. Special instructions.
Since Triombrast® is an iodine-containing drug, in a small amount it can be absorbed by the thyroid gland. Therefore, after the application of Triombrast®, a radioisotope study of the thyroid gland will be uninformative.
If you have allergies in your anamnesis (hay fever, bronchial asthma, drug and food allergies, allergic dermatoses), you should consider the possibility of increased sensitivity to contrast medium and premedication antihistamines. In the case of itching, urticaria, runny nose, edema, a sharp decrease in blood pressure, tachycardia,bronchospasm and other manifestations of hypersensitivity, the use of the drug is contraindicated.
When stored in the cold, part of the active substance in the ampoules can crystallize. The crystals dissolve, dropping the ampoule for several minutes in hot water or heating in a boiling water bath. If the crystals disappear and the solution becomes transparent, and upon cooling to 33-36 ° C the crystals do not fall again, then the solution is usable.